KRBP
Kiromic BioPharma Inc

2,488
Loading...
Loading...
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
35

Frequently Asked Questions

What is Market Cap of Kiromic BioPharma Inc?
What is the 52-week high for Kiromic BioPharma Inc?
What is the 52-week low for Kiromic BioPharma Inc?
What is Kiromic BioPharma Inc stock price today?
What was Kiromic BioPharma Inc stock price yesterday?
What is the PE ratio of Kiromic BioPharma Inc?
What is the Price-to-Book ratio of Kiromic BioPharma Inc?
What is Kiromic BioPharma Inc's EBITDA?
What is the 50-day moving average of Kiromic BioPharma Inc?
How many employess does Kiromic BioPharma Inc has?

Latest KRBP News

View
No KRBP news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.